GeneticTesting.com
Live industry tracker

The genetic testing
industry, all in one place.

1098+ companies, funding rounds, clinical trials, and breakthroughs — tracked daily for founders, investors, and researchers.

Browse by category

View all 1098 companies →

Featured companies

View all →

Recently added

Full directory →
2

23andMe

Genetic Testing ·

AG

ADNTRO GENETICS

Genetic Testing ·

B

BillionToOne

Genetic Testing ·

C

ClarityX

Genetic Testing ·

DC

Dxome CLIA Laboratory

Genetic Testing ·

FG

Fabric Genomics

Genetic Testing ·

F

fetalADN

Genetic Testing ·

G|

G2M | Next Generation IVD solutions for Genomics

Genetic Testing ·

💰

Funding spotlight

🏢

23andMe

Private

🏢

ADNTRO GENETICS

Private

🏢

BillionToOne

Private

🏢

ClarityX

Private

🏢

Dxome CLIA Laboratory

Private

🏢

Fabric Genomics

Private

Latest news

All →
🧬Industry2026-06-23
GRAIL's Galleri Multi-Cancer Early Detection Test Advances Toward Broader Medicare Coverage

GRAIL's Galleri blood test, which screens for over 50 cancer types from a single blood draw, is advancing through a pivotal Medicare coverage pathway that could make it available to millions.

🧬
🧬
🧬
🧬Industry2026-08-28
Genetic Testing Market Projected to Surge Past $62 Billion by 2035 as Clinical Adoption Deepens

The global genetic testing market is forecast to reach $62.61 billion by 2035, driven by oncology, prenatal, and precision medicine demand.

📋Policy2026-08-27
ICE Moves to Expand Rapid DNA Testing for Family Verification at the Border

ICE is seeking to broaden its use of rapid DNA testing to verify familial relationships, raising technical and civil liberties questions.

💰Funding2026-08-26
GenePlanet Secures Strategic Investment from Lauxera in Bid to Become Genomics Unicorn

Slovenia's GenePlanet has landed a strategic investment from Lauxera, setting its sights on unicorn status in the consumer and clinical genomics market.

🧬Industry2026-08-25
Cell-Free DNA Testing Market Targets 2034 as Clinical Adoption Accelerates Across Oncology and Prenatal Care

The cell-free DNA testing market is on a sustained growth trajectory toward 2034, driven by expanding clinical applications and improving technology.

Every Sunday

The Genetic Testing Digest

Funding rounds, breakthroughs, and precision medicine insights — curated weekly for industry professionals.

Subscribe free →

For companies

Reach genomics decision-makers

Premium listings, newsletter sponsorships, and featured placements.

View packages →
🏢

1098+

Companies

across 8 sectors

💰

$12B+

VC Invested

tracked in our database

📰

3×/week

News published

Mon · Wed · Fri

📚

41+

Articles

in our archive

Companies by sector

🧬

14

Consumer

🏥

202

Clinical

🔬

24

Oncology

💊

9

Pharmacogenomics

👶

18

Prenatal

🌳

0

Ancestry

🔭

64

Research

🩺

25

Genetic

Every Sunday

The Genetic Testing Digest

Funding rounds, product launches, research breakthroughs, and the best jobs — curated weekly for the genetic testing industry.

No spam. Unsubscribe anytime.